Becton, Dickinson & Co. (NYSE:BDX) voluntarily expanded the Class I recall of millions of its Q-Syte Luer access devices to include its Nexiva intravenous catheter systems.
The recall, initiated last October, was prompted by complaints that air was introduced in to device through its septum’s bottom disk, potentially leading to air embolisms or leakage that could cause serious injury or death. The Nexiva devices contain two of the Q-Syte components containing the defect, which was caused by a "manufacturing deviation," BD said.